Avidity Partners Management LP
- SEC CIK
- 0001791827
- Latest filing
- Aug 14, 2026
PHAT holding history
Phathom Pharmaceuticals, Inc. in every 13F filed by Avidity Partners Management LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PHAT overviewAll 13F holders of PHATFull Q2 2026 holdings
- Shares (Q2 2026)
- 200,000
- Value
- $2.17M
- % of portfolio
- 0.3%
- Quarters held
- 19
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 200,000 | $2.17M | 0.3% | −49,390−19.8% | Reduced | Holders |
| Q1 2026 | 249,390 | $2.77M | 0.6% | +43,314+21.0% | Added | Holders |
| Q4 2025 | 206,076 | $3.42M | 1.0% | −99,924−32.7% | Reduced | Holders |
| Q3 2025 | 306,000 | $3.60M | 0.8% | −758,500−71.3% | Reduced | Holders |
| Q2 2025 | 1,064,500 | $10.2M | 2.0% | +264,500+33.1% | Added | Holders |
| Q1 2025 | 800,000 | $5.02M | 1.0% | −590,100−42.5% | Reduced | Holders |
| Q4 2024 | 1,390,100 | $11.3M | 1.1% | −414,393−23.0% | Reduced | Holders |
| Q3 2024 | 1,804,493 | $32.6M | 1.7% | +184,493+11.4% | Added | Holders |
| Q2 2024 | 1,620,000 | $16.7M | 0.7% | −115,000−6.6% | Reduced | Holders |
| Q1 2024 | 1,735,000 | $18.4M | 0.7% | +13,420+0.8% | Added | Holders |
| Q4 2023 | 1,721,580 | $15.7M | 0.6% | +104,280+6.4% | Added | Holders |
| Q3 2023 | 1,617,300 | $16.8M | 0.7% | −332,400−17.0% | Reduced | Holders |
| Q2 2023 | 1,949,700 | $27.9M | 1.0% | −98,900−4.8% | Reduced | Holders |
| Q1 2023 | 2,048,600 | $14.6M | 0.5% | +148,600+7.8% | Added | Holders |
| Q4 2022 | 1,900,000 | $21.3M | 0.5% | −6,800−0.4% | Reduced | Holders |
| Q3 2022 | 1,906,800 | $21.1M | 0.5% | −13,000−0.7% | Reduced | Holders |
| Q2 2022 | 1,919,800 | $16.2M | 0.4% | −26,200−1.3% | Reduced | Holders |
| Q1 2022 | 1,946,000 | $26.5M | 0.6% | +50,000+2.6% | Added | Holders |
| Q4 2021 | 1,896,000 | $37.3M | 0.8% | +1,896,000 | New | Holders |